BlackRock Fund Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

BlackRock Fund Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7.82M	Buy	446,293 +58,678	+15%	+$1.12M	﹤0.01%	2710
2016 Q3	$9.22M	Buy	387,615 +26,272	+7%	+$495K	﹤0.01%	2526
2016 Q2	$5.78M	Buy	361,343 +6,082	+2%	+$109K	﹤0.01%	2708
2016 Q1	$7.43M	Sell	355,261 -20,723	-6%	-$370K	﹤0.01%	2521
2015 Q4	$10.2M	Buy	375,984 +19,555	+5%	+$533K	﹤0.01%	2437
2015 Q3	$9.9M	Buy	356,429 +53,455	+18%	+$1.68M	﹤0.01%	2374
2015 Q2	$7.43M	Buy	302,974 +272,612	+898%	+$5.62M	﹤0.01%	2676
2015 Q1	$556K	Sell	30,362 -2,064	-6%	-$41.8K	﹤0.01%	3248
2014 Q4	$598K	Buy	32,426 +5,333	+20%	+$63.3K	﹤0.01%	3247
2014 Q3	$260K	Buy	+27,093	New	+$270K	﹤0.01%	3382

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Fund Advisors's LJPC Position: Q4 2016 in Review

BlackRock Fund Advisors increased its La Jolla Pharmaceutical Company (LJPC) stake by 15% in Q4 2016, buying an estimated $1.12M and bringing the position to 446,293 shares worth $7.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2710.

BlackRock Fund Advisors first reported a position in LJPC in Q3 2014 and has held it in 10 quarters since. The position peaked at $10.2M in Q4 2015. 62 funds tracked by Wall St. Rank hold LJPC as of Q4 2016.

BlackRock Fund Advisors held 446,293 shares of La Jolla Pharmaceutical Company worth $7.82M as of Q4 2016.
BlackRock Fund Advisors bought 58,678 La Jolla Pharmaceutical Company shares in Q4 2016, an estimated $1.12M.
La Jolla Pharmaceutical Company made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2710 holding.
BlackRock Fund Advisors first reported a position in La Jolla Pharmaceutical Company in Q3 2014 and has held it in 10 quarters since.
BlackRock Fund Advisors's La Jolla Pharmaceutical Company position peaked at $10.2M in Q4 2015.
62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.